Actually, substrate trapping trials using catalytically inactive PTP1B D181A confirmed that leptin-activated JAK2 is considered a PTP1B substrate, and that leptin signaling reduction is an obesity resistance mechanism in PTP1B null mice. Here, PTPN1 is linked to obesity disorder.